PHIO PHARMACEUTICALS CORP.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $21.9M | $24.1M |
| FY2022 | — | $10.8M | $11.8M |
| FY2023 | — | $7.7M | $8.5M |
| FY2024 | — | $4.7M | $5.4M |
| FY2025 | — | $20.1M | $21.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $21.9M | $24.1M |
| FY2022 | — | $10.8M | $11.8M |
| FY2023 | — | $7.7M | $8.5M |
| FY2024 | — | $4.7M | $5.4M |
| FY2025 | — | $20.1M | $21.0M |